Discover 2,376 paid clinical trials in Glenview, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor: Society for Vascular Surgery Patient Safety Organization
Sex: All
Age: 18+
Code: NCT02850588
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Glenview IL, Arlington Heights IL, Chicago IL,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Chicago IL, Park Ridge IL, Gurnee IL, Island Lake IL,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
MindWalk Intervention for Older South Asian Caregivers of People With Cognitive Disabilities (CD)
for
Stress, Psychological, Cognitive Decline
Location: Chicago IL, Buffalo Grove IL, Bolingbrook IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 45+
Code: NCT06002919
Recruiting
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
for
Femoro Acetabular Impingement
Location: Des Plaines IL
Sponsor: American Hip Institute
Sex: All
Age: 18 - 60
Code: NCT06500364
Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Niles IL, Chicago IL, Hinsdale IL, Grand Rapids MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Niles IL, Ann Arbor MI, St Louis MO, Louisville KY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Niles IL, Chicago IL, Grand Rapids MI, Rochester MN,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Niles IL, Chicago IL, Zion IL, Detroit MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Niles IL, Grand Rapids MI, St Louis MO, Burnsville MN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase3, Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Niles IL, Grand Rapids MI, Peoria IL, Nashville TN,